MedTrace Logo

Brain Activity and Smoking Cessation

NCT01186055 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2013-07-15

No results posted yet for this study

Summary

In the current study, the investigators propose to test: (1) whether brain activation and connectivity in a resting state, assessed by ASL perfusion MRI, BOLD fMRI, and diffusion tensor imaging (DTI) predicts smoking relapse, and (2) whether brain activation, assessed by BOLD fMRI during performance of neurobehavioral probes for executive cognitive function, stress and cue reactivity, predicts smoking relapse.

Conditions

  • Nicotine Dependence

Interventions

BEHAVIORAL

Smoking Cessation Counseling

Participants shall all receive 8 weeks (6 weeks) of group or individual counseling during their quit attempt.

Sponsors & Collaborators

Principal Investigators

  • Caryn Lerman, PhD · University of Pennsylvania

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2013-02-28
Completion
2013-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01186055 on ClinicalTrials.gov